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Clinical question: What is the best treatment for acute otitis media in children?
Results: Watchful waiting, followed by amoxicillin treatment, if necessary, is the best first-line 
treatment for acute otitis media in children aged six months or older.
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Definition: Acute otitis media (AOM) is an acute bacterial infection of the middle ear fluid. It must 
be clearly distinguished from middle ear effusion, which is noninfected middle ear fluid.
Etiology: Mostly Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella 
catarrhalis. Since the introduction of the PCV7 vaccine, there has been an increase in 
H. influenzae and nonvaccine serotypes of S. pneumoniae.
Incidence: AOM is the most frequent diagnosis in sick children visiting the physician’s office. 
The incidence is maximal at the age of 6–24 months and decreases with age. It is infrequent 
in school-aged children.
Economics: In 2000, it was estimated that AOM accounted for $5 billion of annual expenditure 
in the US.
Level of evidence: Systematic reviews, meta-analyses, randomized controlled trials. Because 
this pathology is very frequent, there are hundreds of papers (from 2001 to current, 260 reviews, 
23 meta-analyses, 31 randomized controlled trials) and it is impossible to give results and a 
reference for each individual paper.
Search sources: PubMed, Cochrane Library, UptoDate (2001 to current)
Outcomes: Time to resolution of symptoms, avoidance of recurrent AOM, avoidance of middle 
ear effusion, avoidance of other complications.
Consumer summary: AOM in children is the most frequent reason for visiting a physician. 
It is self-limiting in most cases, and its complications are rare. There is good evidence that 
watchful waiting for two days followed by antibiotic treatment if necessary is the best treatment. 
No other treatments help, except for the usual pain remedies.
The evidence
Antimicrobial treatment versus watchful waiting?
In children aged six months to 12 years, 7–14 days of antibiotic treatment com-
pared with placebo or watchful waiting provided a more favorable short-term 






There was no difference in disease complications, development 
of persistent middle ear effusion, or recurrence of AOM,1–11 
and a very slight difference for the risk of mastoiditis 
(0.7 versus 2.0/10000).10
Children younger than two years of age with bilateral AOM 
and children with AOM and otorrhea have a higher risk of an 
extended course of disease.2 There is no statistically significant 
effect of antibiotic therapy in preventing development of 
asymptomatic middle ear effusion at one month.12
Choice of antimicrobial treatment?
There are no significant differences in antibiotic effectiveness, 
except in a few individual studies. Almost all of the studies 
conclude that amoxicillin is the first-choice antibiotic, except 
in children with penicillin allergy or those who previously 
did not improve after a course of amoxicillin. See below for 
choice in these situations.
The doses for amoxicillin and amoxicillin-clavulanate 
require consideration of the geographic area where patients 
are treated. A high dose of amoxicillin or amoxicillin-
clavulanate or three doses of ceftriaxone are necessary for 
recurrent or nonresponsive AOM because they are often 
caused by intermediate-resistant S. pneumoniae.13,14
Duration of antimicrobial 
treatment?
Risk of treatment failure is slightly higher with short courses 
of antibiotics (,7 days versus $7 days) one month after 
initiation of therapy (difference of 3% between groups) 
except for ceftriaxone and azithromycin.15,16
Other treatments?
The 7-valent PCV administered during infancy has marginal 
beneficial effects. Administering 7-valent PCV in older 
children with a history of AOM appears to have no benefit in 
preventing further episodes.17 In children 1–7 years of age this 
does not change the rate of recurrent AOM.18 It is not clear if 
administration of influenza vaccine to children does or does 
not reduce occurrence of AOM.19–21 Probiotics do not prevent 
the occurrence of AOM in children aged 10 months to six 
years, but might help in the first year of life.22,23 Echinacea 
purpurea during colds and manipulative osteopathic treatment 
do not prevent the occurrence of AOM in children aged 
1–5 years.2 Decongestants and antihistamines are useless.25 
Ventilation tube insertion leads to a mean reduction of 
1.5 episodes of acute otitis media in the first six months.26 
Adenoidectomy does not prevent recurrent AOM.27
Potential pitfalls
It is important to be trained in otoscopy and have a good 
otoscope, preferably a pneumatic otoscope.
Management
AOM is usually managed by nonspecialists. Indications for 
specialist referral are given below.
Assessment
It is important to recognize that AOM is frequently 
overdiagnosed. Most symptoms described by parents 
correlate poorly with AOM and may simply result from a 
cold. In terms of otoscopic signs, bulging, a cloudy aspect, 
an immobile eardrum on pneumatic otoscopy, and redness 
(from best to worst) have a good association with AOM. Look 
for risk factors, i.e. day care in large groups, use of a pacifier, 
feeding in a supine position, tobacco smoke and air pollution, 
bottle feeding, family history, and underlying disease 
(eg, cleft palate, Down syndrome, immunity problems).
Treatment
Treat every child younger than six months, children six 
months to two years with bilateral AOM, and children with 
otorrhea with antibiotics. Give pain remedies and schedule an 
appointment or at least a telephone follow-up in 48–72 hours 
for all other children with AOM. Treat them with antibiotics 
only if they do not improve.
The first-choice antibiotic is amoxicillin 50 mg/kg/day. In 
countries with a high proportion of intermediate-resistant S. 
pneumoniae, give 90 mg/kg/day (maximum 3 g/day).
For children who have been treated in the previous 
30 days, those with concurrent conjunctivitis, and treatment 
failure after 48–72 hours, choose amoxicillin-clavulanate 
90 mg/kg/day in two divided doses. Treat children older than 
two years for five days and children two years or younger 
for 10 days.
In the event of penicillin allergy with non-type 1 reactions, 
give cefdinir 14 mg/kg/day (maximum 600 mg/day), 
cefpodoxime 10 mg/kg/day (maximum 800 mg/day), or 
cefuroxime 30 mg/kg/day (maximum 1 g/day), all in two 
divided doses. With type 1 reactions, give a macrolide, 
i.e. azithromycin 10 mg/kg/day in one dose (maximum 
500 mg/day) for three days or clarithromycin 15 mg/kg/day 
(maximum 1 g/day) for five days. However, none of these 
agents can eradicate penicillin-resistant S. pneumoniae.International Journal of General Medicine
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An alternative treatment is a single intramuscular dose of 
ceftriaxone 50 mg/kg. If there is no improvement after 48 hours, 
a second dose and even a third dose can be administered.
Give ibuprofen 10 mg/kg three times per day. Check for 
disappearance of middle ear effusion after three months.
Indications for specialist referral
Contact an Ear, Nose and Throat specialist for any child with 
AOM and signs of mastoiditis, facial palsy, sudden vertigo, 
or sudden important hearing loss. Routine referral to an Ear, 
Nose and Throat specialist is advised if middle ear effusion 
has not disappeared after three months.
Further reading
Coker TR, Chan LS, Newberry SJ, et al. Diagnosis, 
microbial epidemiology, and antibiotic treatment of acute 
otitis media in children: A systematic review. JAMA. 
2010;304(19):2161–9.
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